1. Lee WQ, Lie HM, Lie DTT. Diagnosis and treatment of avascular necrosis of the humeral head: Current concepts. J ISAKOS 2023; 8: 108-113.
2. Cheng EY, Mirzaei A, Sugano N, Hernigou P, Jones LC, Koo KH, et al. Osteonecrosis: A more appropriate term than avascular necrosis-pathophysiologic rationale. J Arthroplasty 2025; 40: 2729-2736.
3. Lafforgue P. Pathophysiology and natural history of avascular necrosis of bone. Joint Bone Spine 2006; 73: 500-507.
4. Zhang P, Sun Y, Yang H, Liu D, Zhang F, Zhang Y, et al. Vancomycin-loaded silk fibroin microspheres in an injectable hydrogel for chronic osteomyelitis therapy. Front Bioeng Biotechnol 2023; 11: 1163933.
5. Ahmad F, Torres-Gonzalez L, Sabet A, Simcock X, Fernandez JJ. Avascular necrosis of an adolescent distal radius: A literature review. J Hand Surg Glob Online 2023; 5: 379-381.
6. Itha R, Vaishya R, Vaish A, Migliorini F. Management of chondral and osteochondral lesions of the hip : A comprehensive review. Orthopadie (Heidelb) 2024; 53: 23-38.
7. Cancio-Bello AM, Barlow JD. Avascular necrosis and posttraumatic arthritis after proximal humerus fracture internal fixation: Evaluation and management. Curr Rev Musculoskelet Med 2023; 16: 66-74.
8. Adelaar RS, Madrian JR. Avascular necrosis of the talus. Orthop Clin North Am 2004; 35: 383-395.
9. Bickley MKJ, Li J, Mackay ND, Chapman AWP. Avascular necrosis of the foot and ankle: Aetiology, investigation and management. Orthopaed Trauma 2023; 37: 40-48.
10. Wells ME, Dunn JC. Pathophysiology of avascular necrosis. Hand Clin 2022; 38: 367-376.
11. Ogawa T, Ochiai N, Nishiura Y, Tanaka T, Hara Y. A new treatment strategy for Kienböck’s disease: combination of bone marrow transfusion, low-intensity pulsed ultrasound therapy, and external fixation. J Orthop Sci 2013; 18: 230-237.
12. Mücke T, Krestan CR, Mitchell DA, Kirschke JS, Wutzl A. Bisphosphonate and medication-related osteonecrosis of the jaw: A review. Semin Musculoskelet Radiol 2016; 20: 305-314.
13. Shah KN, Racine J, Jones LC, Aaron RK. Pathophysiology and risk factors for osteonecrosis. Curr Rev Musculoskelet Med 2015; 8: 201-209.
14. Lespasio MJ, Sodhi N, Mont MA. Osteonecrosis of the hip: A primer. Perm J 2019; 23: 18-100.
15. Ashtankar H, Vidya, Jain S. Ayurvedic management of avascular necrosis of femoral head - A case study. J Ayurveda Integr Med Sci 2023; 8: 174-180.
16. Niknafs AM, Giri N, Niewisch MR, Savage SA. Avascular necrosis and minimal trauma fractures in telomere biology disorders. Clin Genet 2026; 109: 286-293.
17. Singh SK, Rajoria K, Sharma S. An Ayurveda approach in the management of avascular necrosis of bilateral hip joint-A case report. J Ayurveda Integr Med 2023; 14: 100792.
18. Khanchandani P, Narayanan A, Naik AA, Kannan V, Pradhan SS, Srimadh Bhagavatham SK, et al. Clinical characteristics, current treatment options, potential mechanisms, biomarkers, and therapeutic targets in avascular necrosis of femoral head. Med Princ Pract 2024; 33: 519-536.
19. Batley MG, Yellin J, Lawrence JT, Wells L, Williams BA. Avascular necrosis of the humeral head in adolescents and young adults-treatment and long-term outcomes. JB JS Open Access 2025; 10: e25.
20. Li M, Chen D, Ma Y, Zheng M, Zheng Q. Stem cell therapy combined with core decompression versus core decompression alone in the treatment of avascular necrosis of the femoral head: A systematic review and meta-analysis. J Orthop Surg Res 2023; 18: 560.
21. Large TM, Adams MR, Loeffler BJ, Gardner MJ. Posttraumatic avascular necrosis after proximal femur, proximal humerus, talar neck, and scaphoid fractures. J Am Acad Orthop Surg 2019; 27: 794-805.
22. Ismailov S, Bacaksiz T, Maden M, Akan I, Onder Y, Kazimoglu C. Does the Hertel criteria correlate with postoperative avascular necrosis and failure in proximal humerus fractures? A retrospective cohort study. Eur J Trauma Emerg Surg 2026; 52: 102.
23. Castillo Mercado JS, Rojas Lievano J, Zaldivar B, Barajas C, Fierro G, González JC. Atraumatic osteonecrosis of the humeral head: Pathophysiology and current concepts of evaluation and treatment. JSES Rev Rep Tech 2022; 2: 277-284.
24. Özkan B, İpteç M, Eren M. Reconstruction of Avascular Necrosis of the Lunate. 2025. p. 173-187.
25. Kazemi M, Daliri M, Moradi A. A systematic review on the management of idiopathic avascular necrosis of the scaphoid (Preiser’s disease). Orthop Traumatol Surg Res 2023; 109: 103480.
26. Amundsen A, Oh C, Huang TCT, Cantwell S, Hsu CC, Moran SL. Avascular necrosis of the scaphoid-preiser disease: Outcomes of 39 surgical cases. J Hand Surg Am 2023; 48: 313.
27. Ko JH, Pet MA, Khouri JS, Hammert WC. Management of scaphoid fractures. Plast Reconstr Surg 2017; 140: 333e-346e.
28. Bain GI, MacLean SB, Yeo CJ, Perilli E, Lichtman DM. The etiology and pathogenesis of kienböck disease. J Wrist Surg 2016; 5: 248-254.
29. Huang JI, Durbhakula MM, Angele P, Johnstone B, Yoo JU. Lunate arthroplasty with autologous mesenchymal stem cells in a rabbit model. J Bone Joint Surg Am 2006; 88: 744-752.
30. Chojnowski K, Opiełka M, Piotrowicz M, Sobocki BK, Napora J, Dąbrowski F, et al. Recent advances in assessment and treatment in kienböck’s disease. J Clin Med 2022; 11: 664.
31. Ikeguchi R, Kakinoki R, Aoyama T, Shibata KR, Otsuka S, Fukiage K, et al. Regeneration of osteonecrosis of canine scapho-lunate using bone marrow stromal cells: Possible therapeutic approach for Kienböck disease. Cell Transplant 2006; 15: 411-422.
32. Berner A, Pfaller C, Dienstknecht T, Zellner J, Müller M, Prantl L, et al. Arthroplasty of the lunate using bone marrow mesenchymal stromal cells. Int Orthop 2011; 35: 379-387.
33. Xie MM, Tang KL, Yuan CS. 3D printing lunate prosthesis for stage IIIc Kienböck’s disease: A case report. Arch Orthop Trauma Surg 2018; 138: 447-451.
34. Murab S, Hawk T, Snyder A, Herold S, Totapally M, Whitlock PW. Tissue engineering strategies for treating avascular necrosis of the femoral head. Bioengineering (Basel) 2021; 8: 200.
35. Teimouri M, Motififard M, Hatami S. Etiology of femoral head avascular necrosis in patients: A cross-sectional study. Adv Biomed Res 2022; 11: 115.
36. Yeghaneh A, Moghtadaei M, Sobhani A, Mahdavi M, Otoukesh B. Prevalence study of femoral head avascular necrosis and evaluating mutual connection between injury and viral infections: Clinical analysis and brief review. J Pharm Res Int 2019; 30: 1-7.
37. Shu P, Sun DL, Shu ZX, Tian S, Pan Q, Wen CJ, et al. Therapeutic applications of genes and gene-engineered mesenchymal stem cells for femoral head necrosis. Hum Gene Ther 2020; 31: 286-296.
38. Lin H, Tang Y, Lozito TP, Oyster N, Wang B, Tuan RS. Efficient in vivo bone formation by BMP-2 engineered human mesenchymal stem cells encapsulated in a projection stereolithographically fabricated hydrogel scaffold. Stem Cell Res Ther 2019; 10: 254.
39. Bian Y, Hu T, Lv Z, Xu Y, Wang Y, Wang H, et al. Bone tissue engineering for treating osteonecrosis of the femoral head. Exploration (Beijing, China) 2023; 3: 20210105.
40. Dong H, Zhu T, Zhang M, Wang D, Wang X, Huang G, et al. Polymer scaffolds-enhanced bone regeneration in osteonecrosis therapy. Front Bioeng Biotechnol 2021; 9: 761302.
41. Mun J, Gillinov S, Kaplan S, Chenna S, Poutre R, Allen B, et al. Surgical management techniques for avascular necrosis of the femoral head: A systematic review. JHPS 2026; 10: 1-11.
42. Wang L, Luo Y, Qiu X, Cheng L, Ma K, Guan J, et al. Analysis of animal models of traumatic osteonecrosis of the femoral head based on blood supply: A literature review. Orthop Surg 2025; 17: 703-713.
43. Zhu ZH, Gao YS, Luo SH, Zeng BF, Zhang CQ. An animal model of femoral head osteonecrosis induced by a single injection of absolute alcohol: An experimental study. Med Sci Monit 2011; 17: Br97-102.
44. Li Z, Shao W, Lv X, Wang B, Han L, Gong S, et al. Advances in experimental models of osteonecrosis of the femoral head. J Orthop Translat 2023; 39: 88-99.
45. Özbaş Z, Özkahraman B, Bayrak G, Kılıç Süloğlu A, Percin I, Boran F, et al. Poly (vinyl alcohol)/(hyaluronic acid-g-kappa-carrageenan) hydrogel as antibiotic-releasing wound dressing. Chem Papers 2021; 75: 6591-6600.
46. Lu X, Guo H, Li J, Sun T, Xiong M. Recombinant human bone morphogenic protein-2 immobilized fabrication of magnesium functionalized injectable hydrogels for controlled-delivery and osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells in femoral head necrosis repair. Front Cell Dev Biol 2021; 9: 723789.
47. Yu R, Ma C, Li G, Xu J, Feng D, Lan X. Inhibition of toll-like receptor 4 signaling pathway accelerates the repair of avascular necrosis of femoral epiphysis through regulating macrophage polarization in perthes disease. Tissue Eng Regen Med 2023; 20: 489-501.
48. Liu D, Zhang Y, Li X, Li J, Yang S, Xing X, et al. eIF2α signaling regulates ischemic osteonecrosis through endoplasmic reticulum stress. Sci Rep 2017; 7: 5062.
49. Cheng JH, Jhan SW, Hsu CC, Chiu HW, Hsu SL. Extracorporeal shockwave therapy modulates the expressions of proinflammatory cytokines IL33 and IL17A, and their receptors ST2 and IL17RA, within the articular cartilage in early avascular necrosis of the femoral head in a rat model. Mediators Inflamm 2021; 2021: 9915877.
50. Guo YJ, Luo SH, Tang MJ, Zhou ZB, Yin JH, Gao YS, et al. Muscone exerts protective roles on alcohol-induced osteonecrosis of the femoral head. Biomed Pharmacother 2018; 97: 825-832.
51. Okazaki S, Nagoya S, Tateda K, Katada R, Mizuo K, Watanabe S, et al. Experimental rat model for alcohol-induced osteonecrosis of the femoral head. Int J Exp Pathol 2013; 94: 312-319.
52. Chen D, Zhang C, Huo H, Ji C, Sun M, Nie L. Injectable temperature-sensitive hydrogel with VEGF loaded microspheres for vascularization and bone regeneration of femoral head necrosis. Mater Lett 2018; 229: 138-141.
53. Wang Y, Zhu W, Xiao K, Li Z, Ma Q, Li W, et al. Self-healing and injectable hybrid hydrogel for bone regeneration of femoral head necrosis and defect. Biochem Biophys Res Commun 2019; 508: 25-30.
54. Motomura G, Yamamoto T, Irisa T, Miyanishi K, Nishida K, Iwamoto Y. Dose effects of corticosteroids on the development of osteonecrosis in rabbits. J Rheumatol 2008; 35: 2395-2399.
55. Peng W, Zhang J, Zhang F, Zhao Y, Dong W. Expression of osteoprotegerin and receptor activator for the nuclear factor-κB ligand in XACB/LV-bFGF/MSCs transplantation for repair of rabbit femoral head defect necrosis. J Cell Biochem 2019; 120: 1427-1434.
56. Wang X, Li J, Man D, Liu R, Zhao J. Early detection of steroid-induced femoral head necrosis using (99m)Tc-Cys-Annexin V-based apoptosis imaging in a rabbit model. Mol Med 2020; 26: 120.
57. Ren Y, Deng Z, Gokani V, Kutschke M, Mitchell TW, Aruwajoye O, et al. Anti-interleukin-6 therapy decreases hip synovitis and bone resorption and increases bone formation following ischemic osteonecrosis of the femoral head. J Bone Miner Res 2021; 36: 357-368.
58. Miashiro EH, Zanella LF, Cardoso GS, Silva GDS, de Angelis K, de Almeida SHM. Animal model standardization for studying avascular necrosis of the femoral head in legg-calvé-perthes disease. Rev Bras Ortop 2023; 58: e771-e780.
59. Wang C, Wu Z, Li X, Shi L, Xie Q, Liu D, et al. An animal model of early-stage femoral head osteonecrosis induced by cryo-insult in small tailed Han sheep. J Orthop Translat 2021; 26: 84-91.
60. Li B, Yu L, Huang Z, Liang Y, Li G, Zhao Y. A novel device for treatment of osteonecrosis of femoral head: Feasibility and preliminary efficacy of animal study. J Orthop Translat 2021; 31: 20-25.
61. Jin H, Xia B, Yu N, He B, Shen Y, Xiao L, et al. The effects of autologous bone marrow mesenchymal stem cell arterial perfusion on vascular repair and angiogenesis in osteonecrosis of the femoral head in dogs. Int Orthop 2012; 36: 2589-96.
62. Gao R, Ji W, Xia T, Fan Y, Wei W, Shi L, et al. Three-dimensional-printed titanium alloy porous scaffold combined with trans-cinnamaldehyde for repairing osteonecrosis of the femoral head in a dog model. Am J Transl Res 2020; 12: 1070-1079.
63. Liu Y, Zhao D, Wang W, Zhang Y, Wang B, Li Z. Efficacy of core decompression for treatment of canine femoral head osteonecrosis induced by arterial ischaemia and venous congestion. Hip Int 2017; 27: 406-411.
64. Rackwitz L, Eden L, Reppenhagen S, Reichert JC, Jakob F, Walles H, et al. Stem cell- and growth factor-based regenerative therapies for avascular necrosis of the femoral head. Stem Cell Res Ther 2012; 3: 7.
65. Lohiya A, Jr., Dhaniwala N, Dudhekar U, Goyal S, Patel SK. A comprehensive review of treatment strategies for early avascular necrosis. Cureus 2023; 15: e50510.
66. Aarvold A, Smith JO, Tayton ER, Jones AM, Dawson JI, Lanham S, et al. A tissue engineering strategy for the treatment of avascular necrosis of the femoral head. Surgeon 2013; 11: 319-325.
67. Dhillon MS, Rana B, Panda I, Patel S, Kumar P. Management options in avascular necrosis of talus. Indian J Orthop 2018; 52: 284-296.
68. Konarski W, Poboży T, Śliwczyński A, Kotela I, Krakowiak J, Hordowicz M, et al. Avascular necrosis of femoral head-overview and current state of the art. Int J Environ Res Public Health 2022; 19: 7348.
69. Kale V. Stem cell-derived extracellular vesicles as a therapeutic for avascular necrosis: Current status and future prospects. Regen Med 2025; 20: 399-408.
70. Fan XL, Wang WT, Wang J, Xiao R. Current management of avascular necrosis of the metacarpal head: A comprehensive literature review. Int J Surg 2023; 109: 1509-1517.
71. Bradley CS, Perry DC, Wedge JH, Murnaghan ML, Kelley SP. Avascular necrosis following closed reduction for treatment of developmental dysplasia of the hip: A systematic review. J Child Orthop 2016; 10: 627-632.
72. Wen Q, Ma L, Chen YP, Yang L, Luo W, Wang XN. Treatment of avascular necrosis of the femoral head by hepatocyte growth factor-transgenic bone marrow stromal stem cells. Gene Ther 2008; 15: 1523-1535.
73. Sousa R, Babulal J, Amado P. Adipose-derived stem cell therapy combined with platelet-rich plasma for the treatment of avascular necrosis of the talus. Cureus 2025; 17: e77578.
74. Pak J, Lee JH, Jeon JH, Lee SH. Complete resolution of avascular necrosis of the human femoral head treated with adipose tissue-derived stem cells and platelet-rich plasma. J Int Med Res 2014; 42: 1353-1362.
75. Kawai T, Shanjani Y, Fazeli S, Behn AW, Okuzu Y, Goodman SB, et al. Customized, degradable, functionally graded scaffold for potential treatment of early stage osteonecrosis of the femoral head. J Orthop Res 2018; 36: 1002-1011.
76. Hu K, Olsen BR. The roles of vascular endothelial growth factor in bone repair and regeneration. Bone 2016; 91: 30-38.
77. Shirin M, Madadi S, Peyravian N, Pezeshkian Z, Rejali L, Hosseini M, et al. A linkage between effectual genes in progression of CRC through canonical and non-canonical TGF-β signaling pathways. Med Oncol 2022; 39: 40.
78. Pezeshkian Z, Forouzesh F, Peyravian N, Yaghoob-Taleghani M, Asadzadeh-Aghdaei H, Zali M, et al. Clinicopathological correlations of VEGF-A and MMP-7 genes expression in different types of colorectal adenoma polyps. WCRJ 2017; 4: e978.
79. Khatibi S, Mojarad EN, Forouzesh F, Pezeshkian Z, Aghdaei HA, Zali MR. Hif-1 alpha gene expression is not a suitable biomarker for evaluating malignancy risk in colorectal polyps. WCRJ 2018; 5: e1128.
80. Sadri S, Aghajani A, Soleimani H, Ghorbani Kalkhajeh S, Nazari H, Brouki Milan P, et al. Exploring the role of the TGF-β Signaling pathway in colorectal precancerous polyps biochemical genetics. Biochem Genet 2025; 63: 1116-1148.
81. Peyravian N, Nobili S, Pezeshkian Z, Olfatifar M, Moradi A, Baghaei K, et al. Increased expression of VANGL1 is predictive of lymph node metastasis in colorectal cancer: Results from a 20-Gene expression signature. J Pers Med 2021; 11: 126.
82. Yan Y, Chen H, Zhang H, Guo C, Yang K, Chen K, et al. Vascularized 3D printed scaffolds for promoting bone regeneration. Biomaterials 2019; 190-191: 97-110.
83. Dou DD, Zhou G, Liu HW, Zhang J, Liu ML, Xiao XF, et al. Sequential releasing of VEGF and BMP-2 in hydroxyapatite collagen scaffolds for bone tissue engineering: Design and characterization. Int J Biol Macromol 2019; 123: 622-628.
84. Chen YP, Chen WC, Wang KC, Chen CH. Effectiveness of synovial fluid mesenchymal stem cells embedded in alginate beads for treatment of steroid-induced avascular necrosis of the femoral head. J Orthop Sci 2014; 19: 657-666.
85. Rezasoltani S, Khatibi S, Pezeshkiyan Z, Nazemalhosseini-Mojarad E, Sharafkhah M, Sadeghi A, et al. Investigating the TLR9 mRNA expression level in different histological types of colorectal polyps. Asian Pac J Cancer Prev 2019; 20: 2299-2302.
86. Kalkhajeh SG, Parsanezhad A, Banoei M, Vahidi M, Kebria MM, Pezeshkian Z, et al. Oncogenic role of cancer stem cell LGR5 in colorectal cancer progression. Can J Med 2021; 3: 189-190.
87. Liao H, Zhong Z, Liu Z, Li L, Ling Z, Zou X. Bone mesenchymal stem cells co-expressing VEGF and BMP-6 genes to combat avascular necrosis of the femoral head. Exp Ther Med 2018; 15: 954-962.
88. Yao Q, Liu Y, Selvaratnam B, Koodali RT, Sun H. Mesoporous silicate nanoparticles/3D nanofibrous scaffold-mediated dual-drug delivery for bone tissue engineering. J Control Release 2018; 279: 69-78.
89. Encarnação IC, Sordi MB, Aragones Á, Müller CMO, Moreira AC, Fernandes CP, et al. Release of simvastatin from scaffolds of poly(lactic-co-glycolic) acid and biphasic ceramic designed for bone tissue regeneration. J Biomed Mater Res B Appl Biomater 2019; 107: 2152-2164.
90. Yao J, Wang Y, Ma W, Dong W, Zhang M, Sun D. Dual-drug-loaded silk fibroin/PLGA scaffolds for potential bone regeneration applications. J Nanomater 2019; 2019: 8050413.
91. Sun Z, Wu F, Gao H, Cui K, Xian M, Zhong J, et al. A dexamethasone-eluting porous scaffold for bone regeneration fabricated by selective laser sintering. ACS Appl Bio Mater 2020; 3: 8739-8747.
92. Momose T, Miyaji H, Kato A, Ogawa K, Yoshida T, Nishida E, et al. Collagen hydrogel scaffold and fibroblast growth factor-2 accelerate periodontal healing of class II furcation defects in dog. Open Dent J 2016; 10: 347-359.
93. Sun L, Xu Z, Zhang Z, Zhao J, Sun M, Gao G, et al. Effects of PRP injection combined with intersecting femoral head decompression versus combined with multiple core decompression in the treatment of avascular necrosis of femoral head-a single-center retrospective cohort study. BMC Musculoskelet Disord 2025; 26: 438.
94. Karakaplan M. Does platelet-rich plasma have a favorable effect in the early stages of steroid-associated femoral head osteonecrosis in a rabbit model? Eklem Hastalik Cerrahisi 2017; 28: 107-113.
95. Sadeghi-Ataabadi M, Mostafavi-Pour Z, Vojdani Z, Sani M, Latifi M, Talaei-Khozani T. Fabrication and characterization of platelet-rich plasma scaffolds for tissue engineering applications. Mater Sci Engineering C Mater Biol Appl 2017; 71: 372-380.
96. Houdek MT, Wyles CC, Collins MS, Howe BM, Terzic A, Behfar A, et al. Stem cells combined with platelet-rich plasma effectively treat corticosteroid-induced osteonecrosis of the hip: A prospective study. Clin Orthop Relat Res 2018; 476: 388-397.
97. D’Ambrosi R, Biancardi E, Massari G, Ragone V, Facchini RM. Survival analysis after core decompression in association with platelet-rich plasma, mesenchymal stem cells, and synthetic bone graft in patients with osteonecrosis of the femoral head. Joints 2018; 6: 16-22.
98. Han J, Gao F, Li Y, Ma J, Sun W, Shi L, et al. The use of platelet-rich plasma for the treatment of osteonecrosis of the femoral head: A systematic review. Biomed Res Int 2020; 2020: 2642439.
99. Huang Z, Wang Q, Zhang T, Fu Y, Wang W. Hyper-activated platelet lysates prevent glucocorticoid-associated femoral head necrosis by regulating autophagy. Biomed Pharmacother 2021; 139: 111711.
100. Aggarwal AK, Poornalingam K, Jain A, Prakash M. Combining platelet-rich plasma instillation with core decompression improves functional outcome and delays progression in early-stage avascular necrosis of femoral head: A 4.5- to 6-year prospective randomized comparative study. J Arthroplasty 2021; 36: 54-61.
101. Li CX, Liu Y, Zhang YZ, Li JC, Lai J. Astragalus polysaccharide: A review of its immunomodulatory effect. Arch Pharm Res 2022; 45: 367-389.
102. Husien S, Ali IH, Mamdouh W. 3D-printing technologies and biomaterial innovations for bone tissue engineering: Current status and future perspectives. J Biomater Sci Polym Ed 2026: 1-36.
103. Parekh SG, Kadakia RJ. Avascular necrosis of the talus. J Am Acad Orthop Surg 2021; 29: e267-e78.
104. Mardones R, Camacho D, Monsalvo F, Zulch N, Jofre C, Minguell JJ. Treatment of osteonecrosis of the femoral head by core decompression and implantation of fully functional ex vivo-expanded bone marrow-derived mesenchymal stem cells: A proof-of-concept study. Stem Cells Cloning 2019; 12: 11-16.
105. Zhu T, Cui Y, Zhang M, Zhao D, Liu G, Ding J. Engineered three-dimensional scaffolds for enhanced bone regeneration in osteonecrosis. Bioact Mater 2020; 5: 584-601.
106. Lai Y, Li Y, Cao H, Long J, Wang X, Li L, et al. Osteogenic magnesium incorporated into PLGA/TCP porous scaffold by 3D printing for repairing challenging bone defect. Biomaterials 2019; 197: 207-219.
107. Qin L, Yao D, Zheng L, Liu WC, Liu Z, Lei M, et al. Phytomolecule icaritin incorporated PLGA/TCP scaffold for steroid-associated osteonecrosis: Proof-of-concept for prevention of hip joint collapse in bipedal emus and mechanistic study in quadrupedal rabbits. Biomaterials 2015; 59: 125-143.
108. Shen J, Wang W, Zhai X, Chen B, Qiao W, Li W, et al. 3D-printed nanocomposite scaffolds with tunable magnesium ionic microenvironment induce in situ bone tissue regeneration. Appl Mater Today 2019; 16: 493-507.
109. Guillaume O, Geven MA, Sprecher CM, Stadelmann VA, Grijpma DW, Tang TT, et al. Surface-enrichment with hydroxyapatite nanoparticles in stereolithography-fabricated composite polymer scaffolds promotes bone repair. Acta Biomater 2017; 54: 386-398.
110. Torres-Sanchez C, Al Mushref FRA, Norrito M, Yendall K, Liu Y, Conway PP. The effect of pore size and porosity on mechanical properties and biological response of porous titanium scaffolds. Mater Sci Eng C Mater Biol Appl 2017; 77: 219-228.
111. Zhou Z, Pan C, Wang N, Zhou L, Shan H, Gao Y, et al. A high-fat diet aggravates osteonecrosis through a macrophage-derived IL-6 pathway. Int Immunol 2019; 31: 263-273.
112. Zhu W, Xu Z, Zhou D, Xu J, He Y, Li ZA. Bioengineering strategies targeting angiogenesis: Innovative solutions for osteonecrosis of the femoral head. J Tissue Eng 2025; 16: 1-27.
113. Lee JS, Hong JM, Jung JW, Shim JH, Oh JH, Cho DW. 3D printing of composite tissue with complex shape applied to ear regeneration. Biofabrication 2014; 6: 024103.
114. Chen M, Le DQ, Baatrup A, Nygaard JV, Hein S, Bjerre L, et al. Self-assembled composite matrix in a hierarchical 3-D scaffold for bone tissue engineering. Acta Biomater 2011; 7: 2244-2255.
115. Peng J, Wen C, Wang A, Wang Y, Xu W, Zhao B, et al. Micro-CT-based bone ceramic scaffolding and its performance after seeding with mesenchymal stem cells for repair of load-bearing bone defect in canine femoral head. J Biomed Mater Res B Appl Biomater 2011; 96: 316-325.
116. Lei H, Zhou Z, Liu L, Gao C, Su Z, Tan Z, et al. Icariin-loaded 3D-printed porous Ti6Al4V reconstruction rods for the treatment of necrotic femoral heads. Acta Biomater 2023; 169: 625-640.
117. Wang X, Xing H, Zhang G, Wu X, Zou X, Feng L, et al. Restoration of a critical mandibular bone defect using human alveolar bone-derived stem cells and porous nano-HA/collagen/PLA scaffold. Stem Cells Int 2016; 2016: 8741641.
118. Lei H, Yi T, Fan H, Pei X, Wu L, Xing F, et al. Customized additive manufacturing of porous Ti6Al4V scaffold with micro-topological structures to regulate cell behavior in bone tissue engineering. Mater Sci Eng C Mater Biol Appl 2021; 120: 111789.
119. Phipps MC, Monte F, Mehta M, Kim HK. Intraosseous delivery of bone morphogenic protein-2 using a self-assembling peptide hydrogel. Biomacromolecules 2016; 17: 2329-2336.
120. Salama AM, Hardy JG, Yessuf AM, Chen J, Ni M, Huang C, et al. Injectable hydrogel technologies for bone disease treatment. ACS Appl Bio Mater 2025; 8: 2691-2715.
121. Feili F, Valadbeigi H, Negahdari B, Khooshnod S, Maleki A, Haddadi M. Injectable hydrogel and its potential therapy for peri-implantitis. Int J Polym Mater Polym Biomater 2025; 75: 1-17.
122. Kim HK, Aruwajoye O, Du J, Kamiya N. Local administration of bone morphogenetic protein-2 and bisphosphonate during non-weight-bearing treatment of ischemic osteonecrosis of the femoral head: An experimental investigation in immature pigs. J Bone Joint Surg Am 2014; 96: 1515-1524.
123. Amoupour M, Kebria MM, Hivechi A, Peyravian N, Ghasemian M, Mehrabi A, et al. Molecular mediators of vasculogenesis and angiogenesis. Biomaterials for vasculogenesis and angiogenesis: Elsevier; 2022. p. 13-37.
124. Aruwajoye OO, Monte F, Kim A, Kim HKW. A comparison of transphyseal neck-head tunneling and multiple epiphyseal drilling on femoral head healing following ischemic osteonecrosis: An experimental investigation in immature pigs. J Pediatr Ortho 2020; 40: 168-175.
125. Xu D, Gan K, Wang Y, Wu Z, Wang Y, Zhang S, et al. A composite deferoxamine/black phosphorus nanosheet/gelatin hydrogel scaffold for ischemic tibial bone repair. Int J Nanomedicine 2022; 17: 1015-1030.
126. Wan Y, Lin Y, Tan X, Gong L, Lei F, Wang C, et al. Injectable hydrogel to deliver bone mesenchymal stem cells preloaded with azithromycin to promote spinal cord repair. ACS Nano 2024; 18: 8934-8951.
127. Pezeshkian Z, Peyravian N, Najafloo R, MalekzadehKebria M, Hadi MJ, Valizadeh H, et al. Insights into cellulose nanocrystals-based bioinks for 3D bioprinting in regenerative medicine and tissue engineering: A review. Int J Biol Macromol 2026; 337: 149409.
128. Xia Y, Chen Z, Zheng Z, Chen H, Chen Y. Nanomaterial-integrated injectable hydrogels for craniofacial bone reconstruction. J Nanobiotechnology 2024; 22: 525.
129. Ma C, Andre G, Edwards D, Kim HKW. A rat model of ischemic osteonecrosis for investigating local therapeutics using biomaterials. Acta Biomater 2021; 132: 260-271.
130. Lu Y, Chen X, Lu X, Sun C, Li M, Chen G, et al. Reconstructing avascular necrotic femoral head through a bioactive β-TCP system: From design to application. Bioactive Mater 2023; 28: 495-510.
131. Aghdaei HA, Pezeshkian Z, Abdollahpour-Alitappeh M, Mojarad EN, Zali MR. The role of angiogenesis in colorectal polyps and cancer: A review. Med Lab J 2018; 12: 1.
132. Yuan S, Han Y, Xiang D, Wang B, Chen Y, Hao Y. An injectable hydroxypropyl-β-cyclodextrin cross-linked gelatin-based hydrogel loaded bone mesenchymal stem cell for osteogenic and in vivo bone regeneration of femoral head necrosis. Nanomedicine 2022; 41: 102521.
133. Sharma D, Hamlet S, Vaquette C, Petcu EB, Ramamurthy P, Ivanovski S. Local delivery of hydrogel encapsulated vascular endothelial growth factor for the prevention of medication-related osteonecrosis of the jaw. Sci Rep 2021; 11: 23371.
134. Peyravian N, Milan PB, Kebria MM, Mashayekhan S, Ghasemian M, Amiri S, et al. Designing and synthesis of injectable hydrogel based on carboxymethyl cellulose/carboxymethyl chitosan containing QK peptide for femoral head osteonecrosis healing. Int J Biol Macromol 2024; 270: 132127.
135. Zhou YH, Zou ZH, Teng JX, Wu ZY, Luo SW, Ning X, et al. Injectable alginate/β-TCP composite hydrogel incorporating P34HB/MgO+PEG coaxial electrospun microfibers for minimally invasive treatment of osteonecrosis. Adv Healthc Mater 2025; 14: e2500617.
136. Yao Z, Liu H, Yang M, Bai Y, Zhang B, Wang C, et al. Bone marrow mesenchymal stem cell-derived endothelial cells increase capillary density and accelerate angiogenesis in mouse hindlimb ischemia model. Stem Cell Res Ther 2020; 11: 221.
137. Zaffagnini M, Boffa A, Andriolo L, Raggi F, Zaffagnini S, Filardo G. Orthobiologic therapies delay the need for hip arthroplasty in patients with avascular necrosis of the femoral head: A systematic review and survival analysis. Knee Surg Sports Traumatol Arthrosc 2025; 33: 1112-1127.
138. Almeida-Matos M, Carrasco J, Lisle L, Castelar M. Avascular necrosis of the femoral head in sickle cell disease in pediatric patients suffering from hip dysfunction. Rev Salud Publica 2016; 18: 986-995.
139. Miric D, Senohradski K, Vucetic C, Djordjevic Z. (Pseudoarthrosis of the scaphoid bone associated with carpal collapse: Factors in choice of surgical approach). Srp Arh Celok lek 2001; 129: 129-134.
)